$QSI

Quantum-Si (QSI) Stock Falls on Q2 2026 Earnings

Quantum-Si Inc. (QSI) reported Q2 2026 revenue of $344,000, above an analyst estimate of $305,020. Diluted EPS was -$0.11, slightly better than expected. The company posted gross profit of $172,000 and an operating loss of $25.6 million, with net loss of $23.5 million. Cash was $23.7 million. Shares fell 1.19% after the release.

Original reporting
Published Aug 13, 2026, 9:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 5:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Quantum-Si (QSI) Stock Falls on Q2 2026 Earnings — source image
Decision brief

The 30-second read

$QSIBearishMed
01

Why it matters

The disclosed earnings datapoints (revenue, EPS, operating loss, net loss, cash used) are the primary driver for trading, with the after-close share drop signaling investor concern about ongoing unprofitability and cash burn.

02

Market read

This is a company-specific earnings release with concrete financial figures and an immediate after-hours price reaction, informing near-term positioning and risk assessment.

03

What to watch

Cash is $23.7M with $18.4M operating cash used; traders may need to assess whether burn rate is improving, but the article does not provide prior-quarter comparisons or guidance.

Relevance 8/10Novelty 7/10Timing: after-hours reaction following Q2 2026 earnings release

Background

The piece summarizes Quantum-Si’s Q2 2026 financial results and notes insider and institutional activity around the period.

Company-level read

Ticker impact

$QSIBearishMedium confidence
Context

Quantum-Si reported Q2 2026 revenue of $344,000 and diluted EPS of -$0.11, with shares down 1.19% after the close.

Expected impact

Near-term downside bias or elevated volatility until profitability milestones or cash runway improve.

Evidence & confidence

The article discloses the quarter’s revenue, EPS, operating loss, and cash burn, plus an after-hours decline, but provides no guidance or balance-sheet change beyond cash and liabilities.

Market effects

Reinforces risk-off sentiment toward pre-profit biotech/quantum-adjacent development-stage names with small revenue bases.

No specific regional spillover described.

No global macro or cross-border catalyst mentioned.

Counterpoint

Revenue beat versus analyst estimate ($344,000 vs $305,020) could support a rebound if investors focus on growth trajectory rather than losses.

Key entities

  • Quantum-Si Inc.

    Reported Q2 2026 revenue of $344,000, diluted EPS of -$0.11, and operating loss of $25.6M; ended with $23.7M cash.

  • QSI insiders

    Insiders reportedly executed 22 trades in 6 months, including 20 sales and 2 purchases.

  • Institutional investors

    Some large funds reduced positions sharply, while AQR added shares in Q1 2026.

Related articles

$QSIMed

Quantum-Si Q2 Earnings Call Highlights

Quantum-Si (NASDAQ:QSI) reported Q2 2026 revenue of $344,000, down from $591,000 a year earlier, and a Q2 net loss of $23.5 million. The company said Proteus launch timing is revised to early 2027, with initial detection of 19 or 20 amino acids. It expects about $12 million annual operating-expense savings and full-year 2026 revenue near $1 million.

$QSIMed

Quantum-Si Inc (QSI): Results of Operations and Financial Condition

Quantum-Si Inc (QSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new mark

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.